Is CEP83 p.Ala232= (c.696G>A) pathogenic?

CEP83 p.Ala232= (c.696G>A) is classified Likely benign in CEP83 (ClinVar, Multiple submitters, 4 submitters; last evaluated 2026-01-12). Rare (popmax 0.544%, mid); Associated with nephronophthisis 18.

What condition is associated with CEP83 p.Ala232= (c.696G>A)?

CEP83 p.Ala232= (c.696G>A) is associated with nephronophthisis 18 (ClinVar).

How common is CEP83 p.Ala232= (c.696G>A) in the general population?

CEP83 p.Ala232= (c.696G>A) is rare (popmax 0.544%, mid) (gnomAD).

How is Nephronophthisis inherited?

Typically Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

CEP83 p.Ala232=

c.696G>A · rs199828197 · VCV1099311

Likely benign Multiple submitters

Classification

Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 4 submitters

gnomAD v4.1

Rare

rare (popmax 0.544%, mid)

Conditions

nephronophthisis 18

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -1.1	GERP -4.1, phastCons 0.003
Overall
CADD	8.236	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.544% Middle Eastern · 33/6,062 alleles

Filtering AF 0.398% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.348%

Overall 0.0104% 168/1,614,038 alleles · rare

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.544%	184
Admixed American	0.0617%	1,622
Remaining individualsnot grpmax-eligible	0.024%	4,167
South Asian	0.00988%	10,120
European (non-Finnish)	0.00585%	17,101
African / African-American	0.00533%	18,758
East Asian	0.00223%	44,866

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CEP83
Protein: p.Ala232=
Coding: c.696G>A
MANE Select: NM_016122
dbSNP: rs199828197
Type: single nucleotide variant
Location: chr12:94378896 (GRCh38)
Gene constraint: LOEUF 0.807 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 81.90

Full CEP83 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nephronophthisis 18 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Nephronophthisis (Orphanet):

Inheritance: Autosomal recessive
Onset: Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Prevalence: 1-9 / 100 000 (Finland)

Similar variants

CEP83 p.Ala232Val Uncertain significance ★★ ⚠ same residue
CEP83 p.Arg209Ter Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Arg215Ter Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Arg511Pro Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Arg511Ter Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Gln81Ter Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Leu351Ter Pathogenic/Likely pathogenic ★★ same condition
CEP83 p.Ala243Val Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep83-p-ala232 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown